1-8 of 8
Matthew J. Cullen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abortive Plasma Cell Differentiation with Loss of Mature B-Cell Phenotype in a Subset of Patients with De Novo Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma: Relevance of cMYC Rearrangements.

Matthew J. Cullen, MSc, Sharon L. Barrans, PhD, Stephen J. Richards, PhD, Andy C. Rawstron, PhD, Sheila J.M. O’Connor, PhD, Reuben M. Tooze, PhD, Roger G. Owen, MD, Andrew Jack, MD
Journal: Blood
Blood (2006) 108 (11): 4643.
https://doi.org/10.1182/blood.V108.11.4643.4643
Published: 2006
Journal Articles

Blockade of Intravascular Hemolysis in PNH with the Terminal Complement Inhibitor Eculizumab Unmasks Low-Level Hemolysis Potentially Occurring through C3 Opsonization.

Anita Hill, MD, Russell P. Rother, PhD, Antonio M. Risitano, PhD, Duncan S. Cole, PhD, Matthew J. Cullen, MSc, Stephen J. Richards, PhD, Carmine Selleri, MD, Patrizia Ricci, BSc, Bruno Rotoli, MD, Lucio Luzzatto, PhD, Peter Hillmen, PhD
Journal: Blood
Blood (2006) 108 (11): 972.
https://doi.org/10.1182/blood.V108.11.972.972
Published: 2006
Journal Articles

The Incidence and Prevalence of Paroxysmal Nocturnal Hemoglobinuria (PNH) and Survival of Patients in Yorkshire.

Anita Hill, MD, Philip J. Platts, MRes, Alex Smith, PhD, Stephen J. Richards, PhD, Matthew J. Cullen, MSc, Quentin A. Hill, MD, Eve Roman, PhD, Peter Hillmen, PhD
Journal: Blood
Blood (2006) 108 (11): 985.
https://doi.org/10.1182/blood.V108.11.985.985
Published: 2006
Journal Articles

Protection of erythrocytes from human complement–mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy

Anita Hill, Simon H. Ridley, Dirk Esser, Rodney G. Oldroyd, Matthew J. Cullen, Paula Kareclas, Seán Gallagher, Geoffrey P. Smith, Stephen J. Richards, Jennifer White, Richard A. G. Smith, Peter Hillmen
Journal: Blood
Blood (2006) 107 (5): 2131–2137.
https://doi.org/10.1182/blood-2005-02-0782
Published: 2006
Journal Articles

The Effect of Eculizumab Therapy on Red Cell Response Kinetics in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Stephen J. Richards, PhD, Matthew J. Cullen, MSc, Anita J. Dickinson, MSc, Anita Hill, MD, David Buchanon, MA, Louise Arnold, BSc, Modupe Elebute, MD, Russell P. Rother, PhD, Peter Hillmen, PhD
Journal: Blood
Blood (2005) 106 (11): 1047.
https://doi.org/10.1182/blood.V106.11.1047.1047
Published: 2005
Journal Articles

Differential Clearance Kinetics and Phenotypic Alterations of Leukaemic Blast Cells during Induction Therapy for Hyperdiploid and t(12;21) Childhood ALL: Implications for Minimal Residual Disease Detection by Flow Cytometry and Clinical Outcome.

Matthew J. Cullen, MSc, Anita J. Dickinson, MSc, Helen Dickinson, BSc, Michael A. Short, BSc, Paul A.S. Evans, PhD, Sally E. Kinsey, MD, Mike Richards, MD, Stephen J. Richards, PhD
Journal: Blood
Blood (2004) 104 (11): 991.
https://doi.org/10.1182/blood.V104.11.991.991
Published: 2004
Journal Articles

Evolution of GPI-Deficient Clones Predicts Clinical Course in Paroxysmal Nocturnal Haemoglobinuria.

Stephen J. Richards, PhD, Matthew J. Cullen, MSc, Anita J. Dickinson, MSc, Claire Hall, MD, Anita Hill, MD, Peter Hillmen, PhD
Journal: Blood
Blood (2004) 104 (11): 172.
https://doi.org/10.1182/blood.V104.11.172.172
Published: 2004
Journal Articles

Early prediction of outcome and response to alemtuzumab therapy in chronic lymphocytic leukemia

Clinical Trials & Observations
Andy C. Rawstron, Ben Kennedy, Paul Moreton, Anita J. Dickinson, Matthew J. Cullen, Stephen J. Richards, Andrew S. Jack, Peter Hillmen
Journal: Blood
Blood (2004) 103 (6): 2027–2031.
https://doi.org/10.1182/blood-2002-10-3270
Published: 2004